Danilo Cimadomo is the Science and Research manager of GeneraLife IVF.
He received his BSc and MSc degrees at the University of Pavia in "Medical Biotechnologies” and "Molecular Biology and Genetics”, and its PhD at the University of Rome "Sapienza” in "Morphogenesis and Tissue Engineering”.
After two internships at the University of Pavia and at the University of Cambridge, he started working at G.en.e.r.a. where he contributed to the validation, implementation, and monitoring of a blastocyst stage PGT programme.
His research is mainly focused on the strategies to improve embryo selection, and he is Author of over 80 papers published in peer-reviewed journals.
He is part of the Executive Committee of the Italian Society of embryology, reproduction, and research (SIERR), and Basic Science officer of the ESHRE special interest group in implantation and early pregnancy (SIGIEP).
He was part of the ESHRE working group that updated the good practice recommendations for embryo biopsy in IVF and he is currently part of the working group that is drafting the good practice recommendations for the definition, diagnosis and treatment of repeated implantation failure (RIF).
He serves as reviewer for several journals in the field of reproductive medicine and embryology, and he is associate editor of Human Reproduction Update.